Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2019, Article ID 6360503, 9 pages
https://doi.org/10.1155/2019/6360503
Research Article

Extracellular Signal-Regulated Kinase Mediates Ebastine-Induced Human Follicle Dermal Papilla Cell Proliferation

1Department of Research, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, New Taipei City 231, Taiwan
2Division of General Surgery, Department of Surgery, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, New Taipei City 231, Taiwan
3Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan
4Radiation Biology Core Laboratory, Institute for Radiological Research, Chang Gung University/Chang Gung Memorial Hospital, Linkou, Taoyuan 333, Taiwan
5Department of Dermatology, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, New Taipei City 231, Taiwan
6School of Medicine, Tzu Chi University, Hualien 970, Taiwan

Correspondence should be addressed to Chun-Hua Wang; moc.liamg@gnawamred

Received 30 October 2018; Revised 31 December 2018; Accepted 23 January 2019; Published 11 February 2019

Academic Editor: Maxim E. Darvin

Copyright © 2019 Fu-Ming Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Panula, P. L. Chazot, M. Cowart et al., “International union of basic and clinical pharmacology. XCVIII. histamine receptors,” Pharmacological Reviews, vol. 67, no. 3, pp. 601–655, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Nemeth, T. Wilson, B. Rada et al., “Characterization and function of histamine receptors in human bone marrow stromal cells,” Stem Cells, vol. 30, no. 2, pp. 222–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Sastre, “Ebastine in allergic rhinitis and chronic idiopathic urticaria,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 63, no. 89, pp. 1–20, 2008. View at Google Scholar · View at Scopus
  4. P. Gehanno, C. Bremard-Oury, and P. Zeisser, “Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults,” Annals of Allergy, Asthma & Immunology, vol. 76, no. 6, pp. 507–512, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. P. H. Ratner, J. C. Lim, and G. C. Georges, “Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis,” The Journal of Allergy and Clinical Immunology, vol. 105, no. 6, pp. 1101–1107, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Llupià, J. Gras, and J. Llenas, “Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models,” Arzneimittel-Forschung/Drug Research, vol. 53, no. 2, pp. 93–97, 2003. View at Google Scholar · View at Scopus
  7. H. Liu and J. M. Farley, “Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transport,” BMC Pharmacology, vol. 5, 8 pages, 2005. View at Google Scholar · View at Scopus
  8. D. S. Church and M. K. Church, “Pharmacology of antihistamines,” World Allergy Organization Journal, vol. 4, no. 3, pp. S22–S27, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Kuna, D. Jurkiewicz, M. M. Czarnecka-Operacz et al., “The role and choice criteria of antihistamines in allergy management - expert opinion,” Postepy Dermatologii i Alergologii, vol. 33, no. 6, pp. 397–410, 2016. View at Google Scholar · View at Scopus
  10. M. Metz, E. Doyle, C. Bindslev-Jensen, T. Watanabe, T. Zuberbier, and M. Maurer, “Effects of antihistamines on innate immune responses to severe bacterial infection in mice,” International Archives of Allergy and Immunology, vol. 155, no. 4, pp. 355–360, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. O'Mahony, M. Akdis, and C. A. Akdis, “Regulation of the immune response and inflammation by histamine and histamine receptors,” The Journal of Allergy and Clinical Immunology, vol. 128, no. 6, pp. 1153–1162, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Canonica and M. Blaiss, “Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: A review of the evidence,” World Allergy Organization Journal, vol. 4, no. 2, pp. 47–53, 2011. View at Google Scholar · View at Scopus
  13. Y. Yoshizawa and S. Kawana, “Efficacy of Ebastine in the Treatment of Alopecia Areata,” Japanese Journal of Dermatology, vol. 115, no. 10, pp. 1473–1480, 2005. View at Google Scholar
  14. M. Ohyama, A. Shimizu, K. Tanaka, and M. Amagai, “Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata,” Journal of Dermatological Science, vol. 58, no. 2, pp. 154–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Inui, T. Nakajima, N. Toda, and S. Itami, “Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases,” The Journal of Dermatology, vol. 36, no. 6, pp. 323–327, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Nori, S. Iwata, Y. Munakata, H. Kobayashi et al., “Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines,” Clinical & Experimental Allergy, vol. 33, no. 11, pp. 1544–1554, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-C. Yang and G. Cotsarelis, “Review of hair follicle dermal cells,” Journal of Dermatological Science, vol. 57, no. 1, pp. 2–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Vincent, R. Liminana, P. Meredith, and J. Reid, “The pharmacokinetics, antihistamine and concentration‐effect relationship of ebastine in healthy subjects.,” British Journal of Clinical Pharmacology, vol. 26, no. 5, pp. 497–502, 1988. View at Publisher · View at Google Scholar · View at Scopus
  19. H.-X. Liu, B. S. Henson, Y. Zhou, N. J. D'Silva, and C. M. Mistretta, “Fungiform papilla pattern: EGF regulates inter-papilla lingual epithelium and decreases papilla number by means of PI3K/Akt, MEK/ERK, and p38 MAPK signaling,” Developmental Dynamics, vol. 237, no. 9, pp. 2378–2393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shahid, T. Tripathi, F. Sobia, S. Moin, M. Siddiqui, and R. A. Khan, “Histamine, histamine receptors, and their role in immunomodulation: an updated systematic review,” Open Immunology Journal, vol. 2, no. 1, pp. 9–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Hamada and K. Suzuki, “Study on histamine related enzyme activities during murine hair cycle,” Journal of Experimental Animal Science, vol. 46, no. 4, pp. 319–322, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. K.-H. Liu, M.-G. Kim, D.-J. Lee et al., “Characterization of ebastine, hydroxyebastine, and carebastine metabolism by human liver microsomes and expressed cytochrome P450 enzymes: Major roles for CYP2J2 and CYP3A,” Drug Metabolism and Disposition, vol. 34, no. 11, pp. 1793–1797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. D. J. Roberts, “A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist,” Drugs, vol. 52, no. 1, pp. 8–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. B. C. Tilly, L. G. J. Tertoolen, R. Remorie et al., “Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: Action through Ca2+-mobilizing H1 receptors,” The Journal of Cell Biology, vol. 110, no. 4, pp. 1211–1215, 1990. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Gschwandtner, M. Mildner, V. Mlitz et al., “Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 68, no. 1, pp. 37–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Francis, F. Meng, E. Gaudio, and G. Alpini, “Histamine regulation of biliary proliferation,” Journal of Hepatology, vol. 56, no. 5, pp. 1204–1206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Zhang, G. Jiang, N. Song et al., “Extracellular signal-regulated kinase (ERK) activation is required for itch sensation in the spinal cord,” Molecular Brain, vol. 7, article 25, no. 1, 2014. View at Publisher · View at Google Scholar
  28. S. Valencia, A. Hernández-Angeles, L.-E. Soria-Jasso, and J.-A. Arias-Montaño, “Histamine H1 receptor activation inhibits the proliferation of human prostatic adenocarcinoma DU-145 cells,” The Prostate, vol. 48, no. 3, pp. 179–187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. A. M. B. Abiuso, E. Berensztein, R. M. Pagotto et al., “H4 histamine receptors inhibit steroidogenesis and proliferation in Leydig cells,” Journal of Endocrinology, vol. 223, no. 3, pp. 241–253, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ito, “Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata,” Clinical and Developmental Immunology, vol. 2013, Article ID 348546, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Villasante Fricke and M. Miteva, “Epidemiology and burden of alopecia areata: A systematic review,” Clinical, Cosmetic and Investigational Dermatology, vol. 8, pp. 397–403, 2015. View at Google Scholar · View at Scopus
  32. N. Todes-Taylor, R. Turner, G. S. Wood, P. T. Stratte, and V. B. Morhenn, “T cell subpopulaions in alopecia areata,” Journal of the American Academy of Dermatology, vol. 11, no. 2, pp. 216–223, 1984. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Arca, U. Musabak, A. Akar, A. H. Erbil, and H. B. Tastan, “Interferon-gamma in alopecia areata,” European Journal of Dermatology, vol. 14, no. 1, pp. 33–36, 2004. View at Google Scholar
  34. A. Gilhar, Y. Kam, B. Assy, and R. S. Kalish, “Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege,” Journal of Investigative Dermatology, vol. 124, no. 1, pp. 288-289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. R. D. Subramanya, A. B. Coda, and A. A. Sinha, “Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures,” Genomics, vol. 96, no. 3, pp. 146–153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Aram, “Treatment of Female Androgenetic Alopecia With Cimetidine,” International Journal of Dermatology, vol. 26, no. 2, pp. 128–130, 1987. View at Publisher · View at Google Scholar · View at Scopus
  37. D. A. Fenton, J. S. English, and J. D. Wilkinson, “Reversal of male-pattern baldness, hypertrichosis, and accelerated hair and nail growth in patients receiving benoxaprofen,” British Medical Journal, vol. 284, no. 6324, pp. 1228-1229, 1982. View at Publisher · View at Google Scholar · View at Scopus